|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 311/46 | |
| A61K 31/18 |
| (11) | Patento numeris | 3022175 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14748056.0 |
| Europos patento paraiškos padavimo data | 2014-07-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-05-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-11-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/047265 |
| Data | 2014-07-18 |
| (87) | Numeris | WO 2015/010065 |
| Data | 2015-01-22 |
| (30) | Numeris | Data | Šalis |
| 201361856146 P | 2013-07-19 | US |
| (72) |
HADIDA-RUAH, Sara Sabina, US
ANDERSON, Corey, US
TERMIN, Andreas P., US
BEAR, Brian Richard, US
ARUMUGAM, Vijayalaksmi, US
KRENITSKY, Paul, US
JOHNSON, James Philip, US
|
| (73) |
Vertex Pharmaceuticals Incorporated,
50 Northern Avenue, 15th Floor, Boston, MA 02210,
US
|
| (54) | SULFONAMIDES AS MODULATORS OF SODIUM CHANNELS |
| SULFONAMIDES AS MODULATORS OF SODIUM CHANNELS |